Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2019-11-01
2020-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Hypoxic and Normoxic Cerebral Oximetry Levels on Cognitive Functions After Carotid Endarterectomy
NCT05652426
Postoperative Cognitive Dysfunction in Heart Surgery
NCT05406843
The Influence of Cognitive Decline on Quality of Life After Coronary Bypass
NCT03774342
Implementation of a Cognitive Training Program to Reduce the Risk of Postoperative Cognitive Dysfunction
NCT03620968
Feasibility and Acceptability of Home-based Computerised Cognitive Training After Cardiac Surgery
NCT05298540
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this study is to determine whether patients who underwent CPB and CABG, which were preserved under normoxic conditions during the intraoperative period, would have a lower incidence of early and late POCD than those exposed to hyperoxia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
normoxy
Group 1(n=50) FiO2%40, PaO2\<180 ve PaO2≥80mmHg MMSE will be applied to patients before surgery. At the determined measurement times body and blood temperature, SpO2, HR, MAP, PH, blood gas lactate, blood gas base deficit, urine output, PaO2, PaCO2, Htc, FiO2, right and left rSO2 values were monitored.
An rSO2 less than 45% triggered an alarm, the anesthesiologist timed the event, and after 60 seconds initiated an intervention protocol means; PaO2 levels were checked, PaO2\> 100 mmHg was achieved, if not improved, pump blood flow, mean arterial pressure were increased, if there is still no response and hematocrit \<20%, patients were scheduled for erythrocyte transfusion until the rSO2 was restored to at least 60% at both probes.In the postoperative period, at the 24th hour, when routine cardiological controls were performed 1., 3., 6. Simultaneous MMSE will be repeated in months.
procedure: cerebral oxygenation intervention
During the surgery, cerebral oxygenation will be followed and intervention will be made to pH, PaO2, PaCO2, mean arterial pressure, hematocrit when necessary. In addition perfusion flow was maintained at or close to between 2.2-2.5 L/min/m2 . Perfusion pressure was adjusted using a phenylephrine infusion to maintain a mean arterial pressure of 50 to 70 mm Hg.
hyperoxia
Group 2(n=50) FiO2%100, PaO2≥180mmHg MMSE will be applied to patients before surgery. At the determined measurement times body and blood temperature, SpO2, HR, MAP, PH, blood gas lactate, blood gas base deficit, urine output, PaO2, PaCO2, Htc, FiO2, right and left rSO2 values were monitored..In the postoperative period, at the 24th hour, when routine cardiological controls were performed 1., 3., 6. Simultaneous MMSE will be repeated in months.
procedure: cerebral oxygenation intervention
During the surgery, cerebral oxygenation will be followed and intervention will be made to pH, PaO2, PaCO2, mean arterial pressure, hematocrit when necessary. In addition perfusion flow was maintained at or close to between 2.2-2.5 L/min/m2 . Perfusion pressure was adjusted using a phenylephrine infusion to maintain a mean arterial pressure of 50 to 70 mm Hg.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
procedure: cerebral oxygenation intervention
During the surgery, cerebral oxygenation will be followed and intervention will be made to pH, PaO2, PaCO2, mean arterial pressure, hematocrit when necessary. In addition perfusion flow was maintained at or close to between 2.2-2.5 L/min/m2 . Perfusion pressure was adjusted using a phenylephrine infusion to maintain a mean arterial pressure of 50 to 70 mm Hg.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Non-Turkish speaking patients
* presence of end-stage organ failure
* patients requiring emergency coronary surgery
* surgical procedures requiring single lung ventilation
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bursa Yuksek Ihtisas Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tugba Onur
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tuğba T ONUR, MD
Role: PRINCIPAL_INVESTIGATOR
Bursa Yuksek Ihtisas Training and Research Hospital
Ümran Ü KARACA, MD
Role: STUDY_CHAIR
Bursa Yuksek Ihtisas Training and Research Hospital
Filiz F ATA, MD
Role: STUDY_CHAIR
Bursa Yuksek Ihtisas Training and Research Hospital
Halil Erkan H SAYAN, MD
Role: STUDY_CHAIR
Bursa Yuksek Ihtisas Training and Research Hospital
Anıl A ONUR, MD
Role: STUDY_CHAIR
Bursa Yuksek Ihtisas Training and Research Hospital
Canan C YILMAZ, MD
Role: STUDY_CHAIR
Bursa Yuksek Ihtisas Training and Research Hospital
Ayşe Neslihan AN BALKAYA, MD
Role: STUDY_CHAIR
Bursa Yuksek Ihtisas Training and Research Hospital
Cüneyt C ERİŞ
Role: STUDY_CHAIR
Bursa Yuksek Ihtisas Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bursa YIERH
Bursa, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Bursa YIERH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.